Dr. Sarah Psutka
Dr. Sarah Psutka MD, MSc is an Associate Professor of Urology in the Department of Urology at the University of Washington and Fred Hutchinson Cancer Center. She received her undergraduate and medical degrees from Harvard University and completed urology residency training at the Massachusetts General Hospital. She completed a Society of Urologic Oncology Fellowship in Urologic Oncology at the Mayo Clinic, and concurrently obtained her Masters in Clinical and Translational Science.
Dr. Psutka’s clinical efforts are centered on the management of non-muscle-invasive and muscle-invasive bladder cancer, advanced kidney and testis cancer, with a particular focus in the care of older and medically complex patients. In addition to her practice at the University of Washington main campus, she leads the urologic oncology program at Harborview Medical Center and is the Associate Program Director of the UW Society of Urologic Oncology Fellowship Program.
Dr. Psutka’s research focuses on the study and development of personalized, comprehensive risk stratification measures in patients with advanced urologic malignancies. She leads research studying the integration of principles of aging research, comprehensive geriatric assessments, body composition, and resilience in patients with advanced GU malignancies with a focus on patient-centric outcomes and development of prehabilitation interventions using digital health innovations. She is a clinical trialist, currently leading the UW Get Moving Trial (NCT06040762), a randomized controlled trial evaluating a personalized home-based prehabilitation exercise intervention delivered via a digital application. Her research has been funded by the National Institute on Aging (2022-2024 GEMSSTAR award), and the Bladder Cancer Advocacy Network. She was the 2022 Recipient of the Society of Urologic Oncology Young Investigator Award and the 2023 Kidney Cancer Association Christopher G. Wood Rising Star Award. She served as a member of the Board of Directors and Fellowship committee of the Society of Urologic Oncology 2022 – 2024, and currently serves on the SUO Clinical Trials Consortium Board of Directors (Kidney), the AUA Practice Guidelines Committee, and is the Cancer Control Committee Liaison for the SWOG Genitourinary Executive Committee. She was a co-founder of the Society of Women in Urologic Oncology in 2019. Dr. Psutka served as the Senior Editor for the Oncology Section of the AUA Core Curriculum from 2019-2023 and now serves as the Senior Consultant for this section. She is an Associate Editor for European Urology.